Filing Details

Accession Number:
0001209191-12-014155
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-29 19:03:02
Reporting Period:
2012-02-27
Filing Date:
2012-02-29
Accepted Time:
2012-02-29 19:03:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1311175 Richard Goudis 800 W. Olympic Boulevard, #406
Los Angeles CA 90015
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-02-27 1,846 $66.45 123,980 No 4 F Direct
Common Stock Disposition 2012-02-27 10,067 $66.50 113,913 No 4 F Direct
Common Stock Acquisiton 2012-02-27 26,634 $6.82 140,547 No 4 M Direct
Common Stock Disposition 2012-02-27 12,911 $66.50 127,636 No 4 D Direct
Common Stock Acquisiton 2012-02-27 41,667 $6.82 169,303 No 4 M Direct
Common Stock Disposition 2012-02-27 21,730 $66.50 147,573 No 4 D Direct
Common Stock Disposition 2012-02-28 33,660 $65.97 113,913 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 D Direct
No 4 M Direct
No 4 D Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2012-02-27 26,634 $0.00 26,634 $6.82
Common Stock Stock Appreciation Rights Disposition 2012-02-27 41,667 $0.00 41,667 $6.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-02-27 No 4 M Direct
83,333 2019-02-27 No 4 M Direct
Footnotes
  1. Pursuant to the Issuer's 2005 Stock Incentive Plan and the terms of the related award agreement, shares of the Issuer's common stock are issued to the Reporting Person as his restricted stock units vest, with a portion of the newly issued shares automatically withheld by the Issuer to satisfy the resulting withholding tax obligation. This Statement of Changes of Beneficial Ownership has been filed to reflect that withholding of shares due to a recent vesting of restricted stock units held by the Reporting Person. The withholding of the newly issued shares occurred automatically upon the vesting of the restricted stock units, and as such, no investment decision was made by the Reporting Person in connection with this transfer.
  2. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2011.
  3. This transaction was executed in multiple trades at prices ranging from $65.64 to $66.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. These stock appreciation rights were fully vested as of February 27, 2012.
  5. Consists of stock appreciation rights granted under the Herbalife Ltd. 2005 Stock Incentive Plan, of which 20% vested February 27, 2012, 20% will vest February 27, 2013 and the remaining 60% will vest February 27, 2014.